Yuri Nikolaevich Bykov

Yuri Nikolaevich Bykov

Auto-generated profile, based on publicly available information

Yuri Nikolaevich Bykov

Irkutsk State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Open access
PDF file
Natalia A. ShnayderNatalia A. Shnayder
Natalia A. Shnayder
NPN. A. Pekarets
N. A. Pekarets
NPN. I. Pekarets
N. I. Pekarets
YBYu. N. Bykov
Yu. N. Bykov
Violetta V GrechkinaVioletta V Grechkina
Violetta V Grechkina
RNRegina F. Nasyrova
Regina F. Nasyrova
Background. Metabolic syndrome induced by antiepileptic drugs (AED-MetS) is a serious adverse reaction (AR) that reduces the quality of life of patients with epilepsy and increases the risk of comorbid cardiovascular disorders affecting life expectancy. The risk of developing AED-MetS varies depending on various factors that account for a search for sensitive and specific biomarkers to predict its development, prevention, diagnosis and correction as well as related main domains (hypertension, dyslipidemia, central obesity, type 2 diabetes mellitus). Systemic inflammatory response and oxidative stress are important arms in both epileptogenesis and neurodegeneration, as well as AED-MetS pathogenesis.Objective: Systematization of the results from preclinical and clinical studies on the role of circulating blood microRNAs in the development and adverse course of the systemic inflammatory response as one of AED-MetS main domains in patients with epilepsy.Material and methods. The analysis of the results of fundamental and clinical studies on circulating microRNAs as epigenetic biomarkers of systemic inflammatory reactions in the mechanism of MetS and AED-MetS pathogenesis, which were included in the databases Google Scholar, PubMed/MEDLINE, MDPI, Scopus, and eLibrary, was carried out over the last decade (2014– 2024).Results. A systematic review has demonstrated that microRNAs can act as promising epigenetic biomarkers of AED-MetS, however, the role for different microRNAs and their paralogs on the development of this AR varies. As part of the current study, a microRNA signature was proposed depending on the risk and severity of the systemic inflammatory response and associated oxidative stress (the leading mechanisms of AED-MetS pathogenesis). The proposed signature consists of three groups of microRNAs, depending on their role in regulating the systemic inflammatory response: low, medium, and high risk.Conclusion. The role of microRNAs in regulating the systemic inflammatory response in AED-MetS requires to be further investigated and results of basic research translated into real-world clinical practice, since the studied microRNAs can not only trigger and exacerbate AED-MetS, but also initiate or support the neurodegenerative processes underlying epileptogenesis.

26 March 2023 in Baikal Medical Journal
Verified
Journal Article
Open access
PDF file
YVYury N. Vasiliev
Yury N. Vasiliev
ТМТуяна Алексеевна Манжеева
Туяна Алексеевна Манжеева
ЕГЕлена Евгеньевна Голинько
Елена Евгеньевна Голинько
YBYury N. Bykov
Yury N. Bykov
Центральный понтинный миелинолиз – заболевание, характеризующееся острой гибелью клеток миелиновых оболочек в центральной части варолиева моста при сохранении структурного состава нейронов. Слово «понтинный» указывает на область моста мозга (pons – варолиев мост, область мозга), а «миелинолиз» обозначает процесс разрушения миелина нервных клеток моста. Гибели клеток мозга при данной патологии способствует нарушение электролитного баланса и резкое изменение осмотического давления. Центральный понтинный миелинолиз часто развивается у пациентов, страдающих алкоголизмом, нарушением питания, онкологическими заболеваниями, инфекциями и другими состояниями, резко нарушающими электролитный баланс организма. Целью данной работы является описание клинического случая, спровоцированного новой короновирусной инфекцией COVID-19, утяжелившей течение заболевания. Неблагоприятному исходу также способствовало несвоевременное проведение нейровизуализации и позднее обращение за медицинской помощью. В результате анализа данного случая сделан вывод о необходимости клинической настороженности на предмет понтинного миелинолиза и применения необходимых диагностических мероприятий (нейровизуализационные методы, исследование метаболических маркеров). Ранее это редкое заболевание с неблагоприятным исходом не описывалось в корреляционной связи с коронавирусной инфекцией. Ранняя постановка диагноза и назначение адекватной терапии способствует ограничению или предотвращению осложнений болезни.

10 March 2025 in Baikal Medical Journal
Verified
Journal Article
Open access
PDF file
IUIrkutsk State Medical University
Irkutsk State Medical University
YVYuri N. Vasiliev
Yuri N. Vasiliev
ИБИрина Анатольевна Буланкина
Ирина Анатольевна Буланкина
YBYury N. Bykov
Yury N. Bykov
ИГИрина Николаевна Герасимова
Ирина Николаевна Герасимова
ЮВЮрий Николаевич Васильев
Юрий Николаевич Васильев
Background. Facial pain, or prosopalgia, is a multifactorial group of diseases of both the central and peripheral nervous systems. The peculiarity of clinical manifestations of facial pain is the complex anatomical and physiological organization of the facial region, characterized by the diversity and branching of nerves, ganglia, vascular bundles, as well as joint and muscular structures. Pathologic processes in the facial region can have a mixed character, and the neurotic component is often layered on any of their manifestations, which is of great importance in the treatment of prosopalgia of different nature. As a consequence, facial pain is the subject of study of specialists of different clinical profiles - otorhinolaryngologists, dentists, neurologists, ophthalmologists, psychiatrists. One of the most common is the pathology of the trigeminal nerve, while various pathogenetic variants of pain can be present: nociceptive, neuropathic or dysfunctional (nociplastic). However, due to the structural and functional features of the face, combinations of different pain phenomena can be observed in one nosological form. Pain manifestations can be realized by various mechanisms: compression-ischemic, inflammatory, mechanical, reflex and somatogenic. Conclusion. Using generalized knowledge of anatomy, physiology and pathology, it is possible to more reasonably use modern diagnostic methods to establish the correct diagnosis, as well as apply treatment methods based on the canons of evidence-based medicine.

11 July 2025 in Vestnik of North-Eastern Federal University. Medical Sciences
Verified
Journal Article
Open access
PDF file
YBYu. N. Bykov
Yu. N. Bykov
TNT. F. Nurulina
T. F. Nurulina
The strategic goal of the healthcare and social assistance system in the Russian Federation is increasing of human life expectancy. In this aspect, the importance of timely diagnosis and correction of conditions that occur in older people, one of which is sarcopenia, increases. The article presents an analysis of the current scientific literature on sarcopenia, methods of its diagnosis, treatment and prevention.Sarcopenia is characterized by a decrease of muscle tissue and strength as a result of the natural aging process of the body or in conditions of pathology. Primary sarcopenia is distinguished, which is mainly based on hormonal disorders (changes in the secretion of somatotropic hormone and cortisol), as well as a decrease in vitamin D levels. Primary sarcopenia has a more unfavorable prognosis and is more difficult to correct. Secondary sarcopenia occurs with physical inactivity, insufficient protein intake, as well as with oncopathology, intestinal diseases, cardiovascular and endocrine diseases. In this case, there is a comorbidity of pathology and a codependency of the pathogenetic mechanisms of the development of the atrophic process in the muscle tissue.Sarcopenia is not a rare syndrome that occurs in the practical work of specialists of various profiles. However, due to the low awareness of doctors and alertness, it is extremely rare to distinguish it as a separate syndrome. The article provides evaluation scales for the diagnosis of sarcopenia, including in quantitative terms. Insufficient diagnosis of sarcopenia in practice leads to mismanagement and insufficient drug correction of such patients. And this, in turn, prognostically worsens the course of both the underlying disease and comorbid pathology.The medical and social aspect of this condition is of particular importance. Due to the significant prevalence and association with adverse outcomes, patients with sarcopenia require dispensary supervision, timely palliative status, and medical support for a long time.The information provided is of interest to doctors of various specialties, nursing staff, social workers, and relatives of patients. Information about sarcopenic syndrome is constantly updated with new data and research in the fields of immunology, pathophysiology, clinical medicine, pharmacology and nutrition.

19 November 2021 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
TGT. V. Goma
T. V. Goma
NKN. M. Kozlova
N. M. Kozlova
YBYu. N. Bykov
Yu. N. Bykov
The article presents a clinical case of the fatal Mallory- Weiss syndrome, which suddenly developed in an 86-year-old patient with a new coronavirus infection COVID-19, complicated by bilateral polysegmental pneumonia. The patient had no history of gastroesophageal refl ux disease, gastric ulcer or duodenal ulcer. The level of D-dimer on admission was elevated, but the patient was prescribed a reduced dose of anticoagulants (heparin). Despite the initial positive dynamics of the condition, the patient had a wave-like course of COVID-19, followed by the development of Mallory- Weiss syndrome, extremely severe post-hemorrhagic anemia and multiple organ failure, which became the cause of death.

13 March 2025 in Russian Journal of Pain
Verified
Journal Article
Closed access
AAA.V. Amelin
A.V. Amelin
EAE.A. Antipenko
E.A. Antipenko
EBE.R. Barantsevich
E.R. Barantsevich
ABA.E. Barulin
A.E. Barulin
YBYu.N. Bykov
Yu.N. Bykov
ISI.A. Shchukin
I.A. Shchukin
On November 08, 2024 in Moscow, under the auspices of the Russian Society for the Study of Pain (RSSP), a Council of Experts was held, during which leading specialists in the field of neurology, who have a high level of expertise in the treatment of back pain, discussed modern approaches to the therapy of discogenic lumbosacral radiculopathy (DLSR). The Council actualized the leading pathogenetic mechanisms of the disease onset and progression; discussed the mechanisms of pathogenesis, which are currently still insufficiently affected by pharmacotherapeutic intervention. Conservative therapy of DLSR is effective and allows to avoid surgical treatment in the majority (more than 90%) of cases. The leading role in conservative therapy of DLSR is played by informing the patient about the benign nature of DLSR, the possibility of spontaneous regression of disc herniation, methods of kinesiotherapy under the supervision of a specialist, epidural administration of local anesthetics and glucocorticoids in the acute period of the disease. In real practice, non-steroidal anti-inflammatory drugs, anticonvulsants are widely used, but their effectiveness remains controversial, so the search for new methods of conservative therapy is relevant. The experts noted the importance of the approach to the treatment of the problem under consideration from the position of its pathogenesis and discussed the introduction of new groups of drugs, emphasizing the need to expand clinical recommendations in favor of drugs with pathogenetically justified and complex mechanisms of action in back pain. The results of RCTs and the experience of clinical application of parenteral preparation of triterpene saponin escin — L-lysine escinate in different groups of patients with DLSR were discussed in detail. The expediency of conducting a multicenter placebo-controlled study of the efficacy of escin — L-lysine escinate in acute DLSR was noted.